Home > Mutants (Isolated)

Mutants (Isolated) List

National BioResource Project (C. elegans) charges shipping and handling fees for the strains due to Japanese government policy.
For academic users, the fee is 1,800 JPY per strain for normal strains and 3,000 JPY per strain for balanced or backcrossed strains. For commercial companies, the fee is 10,000 JPY and 20,000JPY, respectively.
We will send you an invoice in PDF format via email when the strain(s) you ordered are ready to ship. This usually takes 1-2 weeks. Once you have received the invoice, click on the URL provided in the file and follow the payment instructions on the website. Please note that we currently only accept credit card payments. As soon as the payment is confirmed, we will ship the worms.
If you have any questions, please contact Yoshina Laboratory by e-mail. We appreciate your understanding and cooperation in supporting this project. Please note that sending credit card information via e-mail etc. is very dangerous and we ask researchers never do that. 		Last Update 2026-07-23
Search condition : Pathway = cel00561 (Glycerolipid metabolism - Caenorhabditis elegans (nematode))
Allele NameBalance
  • All
  • Completed
  • Request Available
  • Not Required
OutCross
  • All
  • Completed
  • Request Available
  • Not Accepted
Sequence NameGene NamePhenotype Information from the receiver is posted in the form of a "researcher : phenotype" BalancerRequest
tm11409 Not RequiredRequest Available F13E6.5 F13E6.6 F13E6.8 F13E6.9 T01C1.11 T01C1.7 T01C1.5 T01C1.4 T01C1.2 T01C1.12 F13E6.5 F13E6.6 F13E6.8 F13E6.9 T01C1.11 T01C1.7 T01C1.5 T01C1.4 T01C1.2 T01C1.12 homozygous viable
tm14208 Not RequiredCompleted F37A4.1 F37A4.1 homozygous viable
tm13835 Not RequiredRequest Available F37A4.1 F37A4.t1 F37A4.1 F37A4.t1 homozygous viable
tm13840 Not RequiredRequest Available F42A9.1 F42A9.15 F42A9.9 F42A9.1 F42A9.15 F42A9.9 homozygous viable
tm15526 Not RequiredRequest Available F42A9.11 F42A9.16 F42A9.1 F42A9.11 F42A9.16 F42A9.1 homozygous viable
tm10160 CompletedCompleted F52C9.3 F52C9.3 lethal or sterile qC1[nIs281]
tm5146 Not RequiredNot Accepted F52C9.3 F52C9.3 homozygous viable.
tm5557 Request AvailableNot Accepted F52C9.3 F52C9.3
tm5491 Not RequiredNot Accepted K07B1.4 K07B1.4 homozygous viable.
tm5430 Not RequiredNot Accepted R11F4.1 R11F4.1 homozygous viable.
tm10665 Not RequiredRequest Available T28D9.3 T28D9.3 homozygous viable
tm5127 Not RequiredNot Accepted W02H5.8 W02H5.8 homozygous viable.
tm3245 Not RequiredNot Accepted F59F4.4 acl-1 homozygous viable.
tm3289 Not RequiredNot Accepted F59F4.4 acl-1 homozygous viable.
tm14738 Not RequiredRequest Available F28B3.9 acl-11 homozygous viable
tm13049 Not RequiredRequest Available F28B3.9 acl-11 homozygous viable
tm1785 Not RequiredNot Accepted F28B3.9 acl-11 homozygous viable. Dr. G. Hermann: embryonic birefringent gut granules appear normal.
tm15894 Not RequiredRequest Available F28B3.9 acl-11 homozygous viable
tm3142 Not RequiredNot Accepted T06E8.1 acl-2 homozygous viable.
tm3311 CompletedNot Accepted T06E8.1 acl-2 lethal or sterile. tmC3[tmIs1228]
tm3246 CompletedNot Accepted T06E8.1 acl-2 lethal or sterile. nT1 [qIs51]
tm3340 Not RequiredNot Accepted T06E8.1 acl-2 homozygous viable.
tm15616 Not RequiredCompleted F49H12.6 acl-4 homozygous viable
tm1506 Not RequiredNot Accepted R07E3.5 acl-5 homozygous viable. Dr. H. Arai: WT (brood size, embryonic lethality, larval lethality and growth rate).
tm3452 CompletedNot Accepted F08F3.2 acl-6 lethal or sterile. nT1 [qIs51]
tm3396 Not RequiredNot Accepted F08F3.2 acl-6 homozygous viable.
tm2290 Not RequiredNot Accepted T05H4.1 acl-8 homozygous viable.
tm11832 Not RequiredRequest Available T05H4.1 acl-8 homozygous viable
tm12232 Not RequiredRequest Available ZK40.1 acl-9 homozygous viable
tm2164 Not RequiredNot Accepted ZK40.1 acl-9 homozygous viable
tm5823 CompletedNot Accepted F54D8.3 alh-1 lethal or sterile qC1 [e1259 q339 qIs26]
tm8314 Not RequiredCompleted Y69F12A.2 alh-12 homozygous viable
tm8825 Not RequiredCompleted K04F1.15 alh-2 homozygous viable
tm10919 Not RequiredCompleted K04F1.15 alh-2 homozygous viable
tm1045 Not RequiredNot Accepted F55A11.5 bus-18 homozygous viable. Dr. S. Tuck: no effects on maa-1 mutant.
tm15848 Not RequiredRequest Available F55A11.5 bus-18 homozygous viable
tm10625 Not RequiredCompleted C09E10.2 dgk-1 homozygous viable
tm13113 Not RequiredCompleted C09E10.2 dgk-1 homozygous viable
tm12424 Not RequiredRequest Available F46H6.2 dgk-2 homozygous viable
tm16172 Not RequiredRequest Available F46H6.2 dgk-2 homozygous viable
tm16179 Not RequiredRequest Available F46H6.2 dgk-2 homozygous viable
tm10024 Not RequiredCompleted F42A9.1 dgk-4 homozygous viable
tm12004 Not RequiredRequest Available F42A9.1 dgk-4 homozygous viable
tm14111 Not RequiredCompleted K06A1.6 dgk-5 homozygous viable
tm13377 Not RequiredCompleted C54G7.2 mboa-3 homozygous viable
tm1655 Not RequiredNot Accepted C54G7.2 mboa-3 homozygous viable. Dr. H.C. Korswagen: no defects in Wnt signaling as judged by Q neuroblast migration.
tm3557 Not RequiredNot Accepted C08F8.4 mboa-4 homozygous viable.
tm2967 Not RequiredNot Accepted C08F8.4 mboa-4 homozygous viable
tm12327 Not RequiredRequest Available C08F8.4 mboa-4 homozygous viable
tm2968 Not RequiredNot Accepted C08F8.4 mboa-4 homozygous viable